Recommended Dosage of Metoprolol for Hypertension, Angina, and Heart Failure
For hypertension, angina, and heart failure, metoprolol should be initiated at a low dose and gradually titrated to target doses: metoprolol succinate 12.5-25 mg once daily initially, titrated to 200 mg once daily for heart failure and hypertension; or metoprolol tartrate 25-50 mg twice daily for angina and hypertension.
Metoprolol Formulations and Indications
Metoprolol is available in two primary formulations, each with specific dosing recommendations:
Metoprolol Succinate (Extended-Release):
- Preferred for heart failure and hypertension
- Once-daily dosing
- Maintains more consistent blood levels
Metoprolol Tartrate (Immediate-Release):
- Used for hypertension and angina
- Typically twice-daily dosing
- Also used in acute myocardial infarction settings
Dosing Recommendations by Condition
Heart Failure
- Initial dose: 12.5-25 mg metoprolol succinate once daily 1
- Target dose: 200 mg once daily 1, 2
- Titration: Double the dose every 2 weeks if tolerated 1
- Only use evidence-based beta-blockers (metoprolol succinate, carvedilol, or bisoprolol) as they have demonstrated mortality reduction 2
Hypertension
Metoprolol Succinate:
Metoprolol Tartrate:
Angina Pectoris
- Metoprolol Tartrate:
Acute Myocardial Infarction
- Initial IV phase: Three 5 mg bolus injections at 2-minute intervals 3
- Oral maintenance:
Special Populations and Precautions
Contraindications
- Marked first-degree AV block (PR interval >0.24 sec)
- Second or third-degree heart block without pacemaker
- Severe bronchial asthma
- Cardiogenic shock
- Severe heart failure (for initiation) 2
- Symptomatic bradycardia or hypotension 2
Dose Adjustments
- Elderly patients: Start with lower doses due to potential for decreased hepatic/renal function 3
- Hepatic impairment: Use lower initial doses with cautious titration 3
- Renal impairment: No dose adjustment typically required 3
Monitoring and Follow-up
- Monitor heart rate, blood pressure, and clinical status after each dose titration 1
- Target resting heart rate: 50-60 beats per minute unless limited by side effects 2
- Watch for signs of worsening heart failure, especially during initiation phase
- For patients with borderline bradycardia (HR 50-60 bpm), closer monitoring is essential 1
Clinical Pearls
- "Start low, go slow" approach is essential, particularly in heart failure patients 1
- Beta-blockers should be continued indefinitely in heart failure patients with reduced ejection fraction, even if symptoms improve 1
- The extended-release formulation (succinate) is preferred for heart failure based on mortality benefit evidence 2
- In one comparative trial, carvedilol showed greater mortality reduction than immediate-release metoprolol tartrate, but there have been no direct comparisons between carvedilol and metoprolol succinate at target doses 2
- Metoprolol succinate has been shown to reduce all-cause mortality by 34% in patients with heart failure 2, 1, 5
By following these dosing guidelines and monitoring protocols, metoprolol can effectively reduce morbidity and mortality in patients with hypertension, angina, and heart failure.